【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Systemic Sclerosis (Scleroderma) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Systemic Sclerosis (Scleroderma) 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Actelion Ltd 33
Clinical Trial Overview of Actelion Ltd 33
United Therapeutics Corporation 34
Clinical Trial Overview of United Therapeutics Corporation 34
ISDIN 35
Clinical Trial Overview of ISDIN 35
MediQuest Therapeutics, Inc. 36
Clinical Trial Overview of MediQuest Therapeutics, Inc. 36
MedImmune, LLC 37
Clinical Trial Overview of MedImmune, LLC 37
Celgene Corporation 38
Clinical Trial Overview of Celgene Corporation 38
Benesis Corporation 39
Clinical Trial Overview of Benesis Corporation 39
Actelion Pharmaceuticals Ltd 40
Clinical Trial Overview of Actelion Pharmaceuticals Ltd 40
Daval International Ltd. 41
Clinical Trial Overview of Daval International Ltd. 41
Amira Pharmaceuticals, Inc. 42
Clinical Trial Overview of Amira Pharmaceuticals, Inc. 42
Italfarmaco S.p.A. 43
Clinical Trial Overview of Italfarmaco S.p.A. 43
Apricus Biosciences, Inc. 44
Clinical Trial Overview of Apricus Biosciences, Inc. 44
Active Biotech AB 45
Clinical Trial Overview of Active Biotech AB 45
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Orion Oyj 47
Clinical Trial Overview of Orion Oyj 47
Sanofi 48
Clinical Trial Overview of Sanofi 48
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Hoffmann-La Roche Inc. 50
Clinical Trial Overview of Hoffmann-La Roche Inc. 50
Merck & Co., Inc. 51
Clinical Trial Overview of Merck & Co., Inc. 51
Gilead Sciences, Inc. 52
Clinical Trial Overview of Gilead Sciences, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
Assistance Publique – Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 53
Fred Hutchinson Cancer Research Center 54
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 54
National Institute of Arthritis and Musculoskeletal and Skin Diseases 55
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 55
Duke University 56
Clinical Trial Overview of Duke University 56
Hospital for Special Surgery 57
Clinical Trial Overview of Hospital for Special Surgery 57
Georgetown University 58
Clinical Trial Overview of Georgetown University 58
University of Michigan 59
Clinical Trial Overview of University of Michigan 59
Stanford University 60
Clinical Trial Overview of Stanford University 60
National Center for Research Resources 61
Clinical Trial Overview of National Center for Research Resources 61
Boston University 62
Clinical Trial Overview of Boston University 62
Rouen University Hospital 63
Clinical Trial Overview of Rouen University Hospital 63
University of California, Los Angeles 64
Clinical Trial Overview of University of California, Los Angeles 64
Northwestern University 65
Clinical Trial Overview of Northwestern University 65
The Medical University of Graz 66
Clinical Trial Overview of The Medical University of Graz 66
The National Institute of Allergy and Infectious Diseases 67
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 67
Charite – Universitatsmedizin Berlin 68
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 68
Sanjay Gandhi Postgraduate Institute of Medical Sciences 69
Clinical Trial Overview of Sanjay Gandhi Postgraduate Institute of Medical Sciences 69
Arthritis Research UK 70
Clinical Trial Overview of Arthritis Research UK 70
The University of Florence 71
Clinical Trial Overview of The University of Florence 71
Federal University of Sao Paulo 72
Clinical Trial Overview of Federal University of Sao Paulo 72
Five Key Clinical Profiles 73
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 114
【レポート販売概要】
■ タイトル:Systemic Sclerosis (Scleroderma):グローバル臨床試験レビューH1, 2013■ 英文:Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161314
■ 調査対象地域:グローバル
- 世界の工業用酵素市場動向(2012-2016)TechNavio's analysts forecast the Global Industrial Enzymes market to grow at a CAGR of 7.49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the end-user applications of industrial enzymes. The Global Industrial Enzymes market has also been witnessing an increased use of organic and biodegradable compounds. However, stringent governme …
- オプトカプラの世界市場2017-2021About Optocouplers An optocoupler is essentially a passive optical component that can split or combine optical power transmission data from optical fibers. Furthermore, the optocoupler is designed to transfer electrical signals through light waves to enable coupling with electrical isolation between input and output. An optocoupler primarily prevents the fluctuation in voltages, from damaging or d …
- 水銀の世界市場2015-2019About mercury Mercury is a metal with an atomic number of 80 and is depicted by the symbol Hg in the periodic table. The actual name of mercury, as per the periodic table, is hydragyrum, and it is commonly known as quicksilver. The unique property of mercury, which makes it stand apart from other metals, is that it remains in liquid form at room temperature and pressure. Technavio's analysts forec …
- タルクの世界市場予測(~2023年)The talc market is projected to grow at a CAGR of 4.6% from 2018 to 2023 The global talc market is projected to grow from an estimated USD 2.68 billion in 2018 to USD 3.35 billion by 2023, at a CAGR of 4.6% from 2018 to 2023. Growth of the market can be attributed to the rising demand for talc-reinforced polypropylene from the automotive industry, as automotive components made from talc-reinforced …
- 血管炎(Vasculitis):世界の治験レビュー(2015年上半期版)Vasculitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Vasculitis Global Clinical Trials Review, H1, 2015" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- ゲノム編集/ゲノム工学の世界市場予測(~2022年):技術(CRISPR、TALEN、ZFN)、用途、エンドユーザーThe global genome editing/genome engineering market is projected to reach USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5%. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modi …
- ビッグデータ&ビジネス分析の世界市場:構成要素別(ソフトウェア&サービス)、展開モデル別(オンプレミス&クラウド)、分析ツール別(ダッシュボード&データ可視化、セルフサービスツール、データマイニング&ウェアハウジング、レポート、その他)、用途別(顧客分析、サプライチェーン分析、マーケティング分析、価格分析、空間分析、労働力分析、リスク&信用分析、輸送分析)、産業別(製造、BFSI、ヘルスケア、政府、エネルギー&ユーティリティ、輸送、小売&消費財、IT&通信、教育、その他)Big data analytics is the process of examining large set of data or varied set of data for uncovering useful information, which can help organizations make informed business decisions. In addition, it analyzes business data and information through continuous investigation and exploration of old business performance data to obtain conclusive insights for business planning. Furthermore, big data ana …
- エッジデータセンターの世界市場予測・分析2020-2024Global Edge Data Center Market: About this market Technavio’s edge data center market analysis considers sales from IT infrastructure, general construction, power management systems, cooling systems, security solutions, racks, and DCIM components. Our study also finds the sales of edge data center in APAC, Europe, MEA, North America, and South America. In 2019, the IT infrastructure segment had a …
- エネルギー貯蔵技術(EST)の世界市場2015-2025Visiongain has calculated that the global EST market will see CAPEX of $7.013bn in 2015, including spending on commercial and RD&D operations in the CAES, PHS, Battery, Thermal Energy Storage, Flywheels and Ultracapacitors technology submarkets. This report addresses the development of the global energy storage technologies market, analysing the prospects for 6 technology submarkets and 10 key nat …
- 機内エンターテイメントシステムの世界市場2015-2019About In-flight IFE systems are integral value additions for airlines, primarily on long routes. While IFE systems have been around for some time, the move toward providing in-flight connectivity is relatively new. These services enable passengers to enjoy their in-flight time through a host of programs such as games and movies, and enable airlines to effectively engage their passengers and gain a …
- 世界のConfectionery市場におけるM&A動向(2014年2月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global confectionery market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global confectionery market throughout the month. Additionally, the report provides an overview of all …
- 神経学的バイオマーカーの世界市場2016-2020About Biomarkers Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers. Technavio’s analysts forecast th …
- MVNO Business Plan with Financial Modeling Spreadsheet 2010Written by Thomas Aabo, Virtual Network Operator Specialist, "Prepaid MVNO Business Plan" is a complete business plan based on the launch of an illustrative Mobile Virtual Network Operator (MVNO) known as Vibe. The plan covers all aspects of the Company launch plan including market assessment, funding requirements, financial analysis, market segmentation, marketing strategy and product differentia …
- 音楽の世界市場:コンサートチケット、デジタルミュージック、音楽、音楽出版About Music Market Publishing, digital music, physical music copies, and concert tickets are a few primary revenue sources for the music market. The market growth is attributed to the rising number of vendors and their expanding reach in developing markets, the popularity of concerts, growing number of music schools, and prevalence of digital music formats. In 2015, the Americas accounted for the …
- Eスポーツの世界市場2019-2023Global Esports Market: About this market Technavio’s esports market analysis considers sales from sponsorship, media rights, advertising, publisher fees, and merchandise and ticket sales. Our analysis also considers the sales of esports in APAC, Europe, North America, South America, and MEA. In 2018, the sponsorship segment had a significant market share, and this trend is expected to continue ove …